UK-ISRAEL Hemato-Oncology 2018 Dotan symposium
Varda and Boaz Dotan have founded a unique center in Tel Aviv University. Their generous donation has fostered advanced research of hematological malignancies bringing together physicians and scientists in Tel Aviv University and in the affiliated university hospitals. The ultimate goal of this translational research is to harness biology for the cure of hematological malignancies.
The third international Dotan’s Symposium of hematological malignancies is a special symposium bringing together some of the best translational researchers of hematological malignancies in the UK and Israel. This has been possible thanks to initiative by Prof Paresh Vyas from Oxford and the support of the UK Academic Study Group on Israel and the Middle East. The lectures will cover the state-of-the-art of research of hematopoietic stem cells and their niche, lymphoid and myeloid malignancies. The goal is to foster collaborations between Israeli and UK to promote the cure of hematological cancers.